ACP
PRTA icon

Acuta Capital Partners’s Prothena Corp PRTA Stock Holding History

Acuta Capital Partners’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,300
Closed -$560K – 40
2022
Q4 		$560K Buy
+9,300
New +$545K 0.34% 31

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acuta Capital Partners's PRTA Position: Q1 2023 in Review

Acuta Capital Partners sold out of Prothena Corp (PRTA) in Q1 2023, closing a stake of 9,300 shares — an estimated $560K sold.

Acuta Capital Partners first reported a position in PRTA in Q4 2022 and held it in 1 quarter. The position peaked at $560K in Q4 2022. 191 funds tracked by Wall St. Rank hold PRTA as of Q1 2023.

  • Acuta Capital Partners reported no remaining Prothena Corp position as of Q1 2023 after selling out during the quarter.
  • Acuta Capital Partners sold 9,300 Prothena Corp shares in Q1 2023, an estimated $560K.
  • Acuta Capital Partners first reported a position in Prothena Corp in Q4 2022 and held it in 1 quarter.
  • Acuta Capital Partners's Prothena Corp position peaked at $560K in Q4 2022.
  • 191 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2023.

Based on Acuta Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.